Propensity score matching and overlap weighting reduce that problem
Randomly assigned groups received one of three doses 3 mg, 12 mg, 36 mg or a placebo once a day for 40 weeks
They can still enjoy a meal, but the urgency is gone
"Working with Novo Nordisk, we're pushing forward a new model for how life-changing GLP-1 treatments reach patientsmore affordably and at scale." Since April of 2025, Ro has worked with Novo Nordisk to help more patients access FDA-approved GLP-1 medications at the best available cash prices
A., Kgel-Knabner, I., and Rillig, M
Additionally, reduced sodium intake associated with healthier eating patterns may decrease fluid retention, leading to increased urination as excess fluid is eliminated